About Abiomed

Abiomed (NASDAQ: ABMD) is a leading provider of groundbreaking medical technology that provides circulatory and oxygenation support. The Impella® heart pump platform is designed to enable the heart to rest and recover by improving blood flow and/or temporarily assisting with the pumping function of the heart. The Abiomed Breethe OXY-1 System™ is designed to provide oxygenation while supporting patient mobility.

Financial and Operational Metrics

$848

FY’21 Revenue​
17% 5-Year Revenue CAGR​

27%

FY’21 Operating Margin​
26% 5-Year Operating Income CAGR​

$90M

In Cash with $0 Debt

>1,200

Patents with more than
1,200 patents pending

Latest Press Releases

View All Press Releases

Featured Presentation

Latest Events

Latest Quarterly Reports

View All Quarterly Reports